INSMED Inc. Files 8-K for Financial Statements

TL;DR

INSMED filed an 8-K with financial docs, no major news.

AI Summary

On June 27, 2024, INSMED Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The report confirms INSMED Inc.'s incorporation in Virginia and its principal executive offices located at 700 US Highway 202/206, Bridgewater, New Jersey.

Why It Matters

This 8-K filing serves as a routine update, primarily indicating the submission of financial statements and exhibits. Investors should review the full filing for detailed financial information.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, indicating no immediate material adverse events.

Key Players & Entities

• INSMED Inc. (company) — Registrant
• Virginia (jurisdiction) — State of incorporation
• 700 US Highway 202/206 Bridgewater, New Jersey (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share INSM Nasdaq Global Select
• $225 million — ence, announcing that it has called all $225 million aggregate principal amount of its outst

Filing Documents

• ef20031706_8k.htm (8-K) — 29KB
• ef20031706_ex99-1.htm (EX-99.1) — 13KB
• image0.jpg (GRAPHIC) — 168KB
• 0001140361-24-031492.txt ( ) — 409KB
• insm-20240627.xsd (EX-101.SCH) — 4KB
• insm-20240627_lab.xml (EX-101.LAB) — 21KB
• insm-20240627_pre.xml (EX-101.PRE) — 16KB
• ef20031706_8k_htm.xml (XML) — 4KB

01 — Other Events

Item 8.01 — Other Events On June 27, 2024, Insmed Incorporated (the "Company") issued a press release, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference, announcing that it has called all $225 million aggregate principal amount of its outstanding 1.75% Convertible Senior Notes due 2025 (the "Notes") for redemption. The redemption will be effected pursuant to the terms of the Indenture, dated as of January 26, 2018, as supplemented by the First Supplemental Indenture, dated as of January 26, 2018 (as so supplemented, the "Indenture"), between the Company and Computershare Trust Company, N.A., as successor trustee to Wells Fargo Bank, National Association. All then outstanding Notes will be redeemed on August 9, 2024 (the "Redemption Date") at a redemption price equal to 100% of the principal amount of such Notes, plus accrued and unpaid interest on such Notes to, but excluding, the Redemption Date (the "Redemption Price"). The Notes may be surrendered for conversion at any time before 5:00 p.m., New York City time, on August 8, 2024 (or, if the Company fails to pay the Redemption Price on the Redemption Date, at any time until 5:00 p.m., New York City time, the date on which the Redemption Price is paid). The Company has elected to settle all such conversions of Notes in shares of common stock in accordance with the Indenture. This Current Report on Form 8-K is not a notice of redemption or convertibility of the Notes. The redemption is being made solely pursuant to the Notice of Redemption, dated June 27, 2024, relating to the Notes.

01

Item 9.01

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by Insmed Incorporated, dated June 27, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 27, 2024 INSMED INCORPORATED By: /s/ Michael A. Smith Name: Michael A. Smith Title: Chief Legal Officer and Corporate Secretary